Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

6.01
Delayed Data
As of Feb 05
 -0.25 / -3.99%
Today’s Change
4.50
Today|||52-Week Range
10.83
-10.57%
Year-to-Date

Today’s Trading

Previous close6.26
Today’s open6.18
Day’s range5.96 - 6.27
Volume1,908,598
Average volume (3 months)1,609,822
Market cap$433.4M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)+55.56%
Earnings growth (this year)+38.28%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-22.35%
P/E ratioNM
Price/Sales52.15
Price/Book3.28

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc-1.00-5.53%
ELGXEndologix Inc-0.28-3.72%
ANGOAngioDynamics Inc-0.34-3.20%
LDRHLDR Holding Corp-0.84-4.65%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$10.5M
Annual profit (last year)-$36.1M
Net profit margin-345.44%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts

Partner Offers